Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial
Carlino, Matteo S., Long, Georgina V., Schadendorf, Dirk, Robert, Caroline, Ribas, Antoni, Richtig, Erika, Nyakas, Marta, Caglevic, Christian, Tarhini, Ahmed, Blank, Christian, Hoeller, Christoph, BarVolume:
101
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2018.06.034
Date:
September, 2018
File:
PDF, 451 KB
english, 2018